Urbana–Carle Cancer Center’s commitment to research has attracted the attention of the National Cancer Institute, a division of the National Institutes of Health (NIH). Recently, the NIH selected the Carle Cancer Center Community Clinical Oncology program (CCOP) to be one of just a few across the nation to receive additional funding for research.

As an established CCOP for 24 years, Carle Cancer Center receives annual funding through NIH grants. Second only to Mayo Clinic in past years, the program receives the award based on its strong history of high enrollment in cancer treatment trials.

“This is a great accomplishment for our center and our patients,” said Kendrith Rowland, MD, Principal Investigator of Oncology Research at Carle Clinic. “We are grateful to the patients we serve for their participation in state-of-the-art clinical trials. The more active we and our patients are in clinical trials, the more opportunities we have to bring even more leading-edge care and therapies to our region. In an age of funding restrictions, this is a major accomplishment.”

Carle Cancer Center currently offers more than 170 clinical trials for the prevention, control and treatment of cancer and actively participates in community outreach and education.